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Aim: The objective was to formulate and characterize the nanoemulsion based on Cymbopogon citratus
oil, intended for use in teeth infected root canal therapy. The investigation of the antioxidant and an-
tibiofilm potential toward Enterococcus faecalis was aimed as well. Materials & methods: Characterization
of oil (by GC/MS analysis) and nanoemulsion (by dynamic light scattering instrument), and determination
of antibacterial (by microdilution assay), antibiofilm (by crystal violet assay) and antioxidant properties (by
2,2-diphenyl-1-picryl-hydrazyl-hydrate and thiobarbituric acid assay methods) were provided. Antibiofilm
efficacy of irrigation procedure including nanoemulsion was screened on extracted teeth (by CFU count-
ing assay). Results: Notable antibacterial and antibiofilm activity, both against forming and preformed
biofilms of oil, was observed. Irrigation involved nanoemulsion showed remarkable antibiofilm potential.
Both substances induced some antioxidant activity. Conclusion: Results encourage further research with
the aim of application of the nanoemulsion in dental practice.
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Incidence of Enterococcus faecalis in unsuccessfully treated root canals of the teeth is high and well-documented in
endodontic literature [1,2]. It is due to capability of E. faecalis to invade dentin tubules of the teeth, to form biofilm
within them and to survive exposure to commonly used endodontic antimicrobials, such as sodium hypochlorite
(NaOCl), chlorhexidine and calcium hydroxide [3–6]. Although being routinely used, all of them may be responsible
for the production of reactive oxygen species (ROS) [7–9]. Even though ROS lead to bacterial cell death they also have
side effects, such as causing an inflammation, human cell aging and mutation [7]. If the above-mentioned common
intracanal antimicrobials lack in their efficiency and/or surgical treatment wants to be avoided, antibacterial pastes,
such as triple antibiotic paste (TAP), are used in the endodontic procedure [10–13]. TAP has been commonly
successful in the total elimination of E. faecalis from the root canal [14], though its usage can contribute to antibiotic
resistance [11].
Taking into account all the above-mentioned, discovering novel antimicrobial agents which are at the same time
effective, possess the antioxidant potential and do not lead to bacterial resistance, represents a serious breakthrough
in dental research. Many researchers, aware of the mentioned problems, are in search of alternative antimicrobials
in nature. Therefore, exploring essential oils (EOs), as natural products of well-known antibacterial efficacy, with
no documented resistance issues and with antioxidant potential [15,16], seems to be of special importance for
the dental community. Some of the EOs have already been documented for their inhibitory potential against E.
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faecalis [17]; moreover, our recent research showed the notable activity of Cymbopogon martinii EO against this
intracanal pathogen [18]. The outcomes of our previous studies combined with the literature data documenting
the EOs antioxidant potential [19,20], focused this investigation toward EO from other species of Cymbopogon
genera, namely to a pleasant lime-scented Cymbopogon citratus EO [21]. Moreover, it is worth mentioning that it
has a proven high antibacterial potential against numerous bacteria, including the oral ones [22] and even more the
antibiotic-resistant strains [23]. In addition, C. citratus EO is enriched with antioxidant potential [19,20]. Recognized
antibacterial and antioxidant activities encouraged the investigation of this particular EO for its possible application
in dentistry, particularly against intracanal pathogens.
Therefore, the objective of this study was to investigate the antibacterial, antioxidant and antibiofilm potential of
C. citratus EO toward E. faecalis, and to formulate and characterize nanoemulsion made of it, as a delivery system
being appropriate for the endodontics application. Characterization of the nanoemulsion included not only the
determination of its physicochemical attributes, but also the antibiofilm potential of its application in ex vivo root
canals, as well as its in vitro antioxidant efficacy.
Materials & methods
Antibacterial agents
Cymbopogon citratus EO – origin & chemical characterization
Pure, commercial EO from leaves of C. citratus (DC.) Stapf. (Lemongrass oil), was purchased from Herba d.o.o,
Belgrade, Serbia. TAP, used as a positive control, was composed of the powder of three antibiotics: Metronidazole
(Orvagyl R©, Galenika, Belgrade, Serbia, 400 mg), Ciprofloxacin (Ciprofloxacin R©, Remedica LTD, Limassol, Cyprus,
200 mg) and Minocycline (Minocin R©, Pfizer, NY, USA, 100 mg), mixed in the ratio 1:1:1. This mixture was further
dissolved in sterile distilled water to provide the stock concentration of 1 mg/ml-1.
Procedures for EO GC/FID and GC/MS analyses were described in detail by Marinković et al. [18]. The
identification of the individual EO constituents was accomplished by comparing their spectra to those from
available MS libraries (NIST/Wiley), as well as by comparing their experimentally determined retention indices
(calibrated AMDIS), to the data from the literature [24].
C. citratus EO nanoemulsion – preparation & characterization
C. citratus nanoemulsion was prepared as a mixture of 2.5% of C. citratus EO, 2.5% of ethanol, 0.25% of Tween
80 and 94.75% (v/v) of distilled water. Emulsification was performed by addition of an organic phase (containing
C. citratus EO and nonionic surfactant Tween 80 in ratio 10:1) to an aqueous phase (double distilled water and
ethanol) during magnetic stirring (20 min at 500 r.p.m.) of this mixture at ambient temperature (∼25◦C). After that,
the emulsion was subjected to 15 min of ultrasonification at 10% amplitude (Sonoplus, Ultrasonic homogenizer
HD 2200, Bandelin Electronic, Berlin). Additionally, the EO-nanoemulsion negative control, involving all the
constituents with exception of the EO, was provided. As a positive control, 0.5% NaOCl was used. The prepared
emulsion was stored at 5◦C for 28 days.
The particle size distributions and polydispersity indices of C. citratus EO nanoemulsion were measured using
a dynamic light scattering instrument (Zetasizer Nano ZS, Malvern Instruments, Malvern, UK). This instrument
determines the particle size from intensity–time fluctuations of a laser beam (632.8 nm) scattered from a sample
at an angle of 90◦. Each individual measurement was an average of 13 runs. To avoid multiple scattering effects,
samples were diluted with distilled water (1:100) before measurements. The measurements were provided regularly:
immediately after emulsion synthesis and after 14, 21 and 28 days of storage.
Antioxidant activity
2,2-diphenyl-1-picryl-hydrazyl-hydrate free radical scavenging assay & thiobarbituric acid assay
2,2-diphenyl-1-picryl-hydrazyl-hydrate (DPPH) assay, performed as previously explained [25], was used to evaluate
radical-scavenging activity. On the other hand, thiobarbituric acid assay (TBA) assay, performed with commercial
preparation of liposomes (l-α-phosphatidylcholine) and previously described by Vasilijević et al. [26], was used to
measure the extent of lipid peroxidation (LP). C. citratus EO and EO nanoemulsion were tested, while ascorbic acid
was used as a positive control. Tested concentrations ranges were 0.125–9000 μg ml-1, 14–226 μg ml-1 and 3.125–
200 μg ml-1, for EO, nanoemulsion and positive control, respectively. Tested concentrations for EO-nanoemulsion
were expressed through available EO concentration (active principle) in the nanoemulsion.
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The absorbance (A) of remaining DPPH radical (DPPH assay) and of extent of LP (TBA assay) were mea-
sured spectrophotometrically at 517 and 532 nm, respectively (UV-6300 PC spectrophotometer, MRC, Scientific
Instruments, Holon, Israel). The inhibition of DPPH/LP was calculated using the following equation:
I = 100% × (Acontrol − Atestsubstance) ÷ Acontrol
Where applicable, the concentration providing 50% inhibition (IC50) was read off from the graph plotting
scavenging activity as a function of test substance concentration. Experiments were performed twice in triplicate.
Microbiological assessment
Bacterial strains
The clinical isolates of E. faecalis EFc11, EFc12 and EFc13 were sampled from both symptomatic and asymptomatic
infected root canals at the Department of Pediatric and Preventive Dentistry, School of Dental Medicine, University
of Belgrade, Serbia [27]. Reference strains E. faecalis ATCC 29212 and ATCC 194303 were also included.
Antibacterial activity of C. citratus EO
Minimal inhibitory and bactericidal concentrations (MICs and MBCs) were determined by the resazurin-
incorporated microdilution method using 96-well microtiter plates. MICs and MBC have been determined by the
procedure previously described by Nikolić et al. [28], with only one modification: to increase EO solubility instead
of dimethyl sulfoxide (DMSO) surfactant Tween 80 was used (EO: Tween 80 ratio was 1:1). Bacterial inoculums
were 105 CFU ml-1, while the tested concentration range of EO was 4–0.03125 μg ml-1. The experiment was done
in triplicate and repeated twice.
Antibiofilm activity of C. citratus EO
The impact of C. citratus EO on formation and eradication of biofilm was screened on E. faecalis ATCC 29212,
used as a model organism. Crystal violet (CV) assay was performed as previously described by Stepanović et al. [29],
but with slight modifications.
Concerning the effect on the biofilm formation, the bacterial cell suspensions (106 CFU ml-1) and serially
diluted antibacterial agent (MIC/8-MIC) were prepared separately in the Tryptic soy broth enriched with 2%
glucose. By mixing 100 μl of bacterial inoculums and 100 μl of test agent dilutions into 96-well microtiter plates
with flat bottom (Sarstedt, Germany), the final inoculums (5 × 104 CFU/well) and final concentrations ranging
MIC/16–MIC/2 were adjusted. The plates were incubated at 37◦C, for 24 h to allow biofilm formation with
and without test agents. Following a biofilm formation, the medium was aspirated and planktonic cells have been
removed by washing the medium twice with sterile saline. The cells were fixed with 200 μl of methanol/well,
which was removed after 10 min, and the plates were air-dried for 30 min. The biofilm was stained in each well
by adding 200 μl of 0.1% CV (Bio-Merieux, Marcy-l’Etoile, France). After 30 min, the wells were washed, while
the remaining stain, bound to biofilms, was resuspended in 96% ethanol (200 μl per well). The absorbance (A)
was read at 620 nm on Multiskan™ FC Microplate Photometer, Thermo Fisher Scientific™. Percentage of the
inhibition of biofilm formation was calculated according to following equitation:
I = 100% × (Acontrol − Atreatment) ÷ Acontrol
Concerning the effect on the biofilm disruption, the bacterial cell suspensions (106 CFU ml-1) prepared in the same
medium was added into 96-well microtiter plates with flat bottom (200 μl/well) and incubated at 37◦C, for 24 h,
to allow biofilm preformation. Following a biofilm formation, the medium was replaced with the same volumes
(200 μl/well) of medium containing test agents (MIC/4–MIC/2) were added and additional 24 h incubation at
37◦C was provided. Following procedure was exactly the same as previously described, resulting in absorbance at
620 nm determination and percentage of biofilm disruption calculation.
For both inhibitions of formation and disruption of biofilms, the experiments were done in five replicas per
treatment point and repeated twice. TAP was used as a positive control.
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Table 1. Experimental irrigation procedures.
Irrigation procedure† First irrigant solution‡ Intermediate irrigant solution§ The final irrigant solution
A – test procedure NaOCl Sterile saline EO nanoemulsion¶
B – negative control NaOCl Sterile saline EO-nanoemulsion negative control#
C – without the final irrigation NaOCl - -
†Volume of each irrigant solution was set to be 2 ml.
‡NaOCl solution contained 0.5% of active Cl2.
§ Intermediate irrigation with sterile saline is commonly used in dentistry, in order to avoid any interaction between the irrigant solutions.
¶Nanoemulsion content: Cymbopogon citratus EO (2.5%, v/v), Tween 80 (0.25%, v/v), ethanol (2.5%, v/v), distilled water (added to 100% content).
#Nanoemulsion negative control content: Tween 80 (0.25%, v/v), ethanol (2.5%, v/v), distilled water (added to 100% content).
EO: Essential oil.
Antibiofilm activity of C. citratus EO nanoemulsion
Monitoring of antibiofilm potential of C. citratus EO nanoemulsion was provided by CFU-counting assay performed
to monitor the biofilm disruption within the root canals of the extracted teeth [30]. The detailed procedure of biofilm
cultivation and CFU determination has already been described in our recent publication [18]. In brief, it included
root canal preparation at working length, its proper disinfection and sterilization by autoclaving of the extracted
teeth. When sterility within the root canal was achieved and confirmed, E. faecalis inoculums (2 × 104 CFU/root
canal in volume 20 μl) were initially introduced into root canals and repeated periodically every 48 h, along a 15 day
time period. During the entire cultivation period, the root canal samples were incubated at 37◦C. To monitor the
efficiency of C. citratus EO nanoemulsion to enhance the antibiofilm activity, the following experimental design
has been provided (Table 1). Experimental irrigation procedure is actually procedure A, including the biofilms
treatment with NaOCl 0.5%, sterile saline and EO nanoemulsion. This procedure was compared with adequate
controls (procedures B and C). Concerning irrigation procedure B, this involved successive irrigation with NaOCl,
sterile saline and EO-nanoemulsion negative control. In addition, the irrigation involving NaOCl only was also
provided (irrigation procedure C). After irrigation, sampling was provided by sterile paper point (#30) and values
of log CFU ml-1 was determined by plating on blood agar, both applied as previously explained by Marinković
et al. [18]. Intracanal biofilm disruption assay was performed in two individual experiments, in triplicate.
Statistical analysis
One-way analysis of variance test was used in SPSS 20.0 (IBM Corporation) statistical software. All p-values less
than 0.05 were considered significant.
Results
C. citratus EO composition
Analysis of C. citratus EO revealed the abundance in oxygenated monoterpenes, and among them, citrals A
(45.7%), B (31.6%) and geraniol (5.9%) were the major constituents (Table 2). Oxygenated monoterpenes
(93.37%) comprised the major chemical group of the EO, followed by monoterpene hydrocarbons (3.41%),
sesquiterpene hydrocarbons (2.45%) and oxygenated sesquiterpenes (0.36%).
Antioxidant activity of C. citratus EO
In the DPPH assay notable DPPH scavenging potential of the C. citratus EO was observed, with IC50 valuing
1.8 mg ml-1 (Figure 1A). The TBA assay also confirmed the notable antioxidant potential of the EO, ranging from
30.6 to 47.3% of inhibition, but the IC50 value could not be determined (Figure 1B).
Antibacterial activity of C. citratus EO
Results of the evaluation of antibacterial activity of C. citratus EO is shown in Table 3. Inhibitory potential of C.
citratus EO ranged between 0.5 and 2 mg ml-1 and it was higher than that of positive control TAP. Bactericidal
potential of both tested substances has been, in general, two-times lower in comparison to their inhibitory potential.
Antibiofilm activity of C. citratus EO
The CV assay revealed the significant inhibitory effect of EO on the biofilm formation (Figure 2A), as well as its
disruptive potential on the preformed biofilm (Figure 2B, p < 0.05).
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Table 2. Chemical composition of Cymbopogon citratus EO (% w/w).
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Figure 1. Antioxidative potential of the
Cymbopogon citratus essential oil. Presented
values are averages with standard deviations,
obtained for two individual experiments
performed in triplicates.
TBA: Thiobarbituric acid assay.
Table 3. Minimal inhibitory concentrations and minimal bactericidal concentrations of Cymbopogon citratus EO
toward Enterococcus faecalis (mg ml-1, average ± standard deviation).
E. faecalis C. citratus EO TAP
Clinical isolate†/reference strain MIC MBC MIC MBC
Isolate EFc11 0.50 ± 0.00 1.00 ± 0.00 0.013 ± 0.00 0.025 ± 0.00
Isolate EFc12 1.00 ± 0.00 2.00 ± 0.00 0.025 ± 0.00 0.025 ± 0.00
Isolate EFc13 2.00 ± 0.00 4.00 ± 0.00 0.025 ± 0.00 0.050 ± 0.00
ATCC 29212 1.00 ± 0.00 2.00 ± 0.00 0.025 ± 0.00 0.050 ± 0.00
ATCC 194303 0.50 ± 0.00 1.00 ± 0.00 0.013 ± 0.00 0.025 ± 0.00
† Isolates of E. faecalis originated from infected root canals.
EO: Essential oil; MBC: Minimal bactericidal concentration; MIC: Minimal inhibitory concentration; TAP: Triple antibiotic paste.
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Figure 2. In vitro effect of C. citratus essential oil in the crystal violet assay. (A) On the biofilm formation and (B) on
the pre-formed biofilm. The results are expressed as the average ± standard deviation of two individual experiments,
each performed in five replicas. Statistical significance was tested using the one-way ANOVA.
*p < 0.05; statistical difference in the biofilm biomass compared with the untreated control (100% biofilm biomass).
EO: Essential oil; TAP: Triple antibiotic paste.
Table 4. Behavior of Cymbopogon citratus EO nanoemulsion NWD and PDI with time.
Day 0 14 21 28
NWD (nm) 95 ± 23 121 ± 8 127 ± 11 109 ± 24
PDI 0.17 ± 3 0.15 ± 1 0.15 ± 3 0.15 ± 2
EO: Essential oil; NWD: Number-weighted mean particle diameter; PDI: Polydispersity index.
Impact of C. citratus EO on the biofilm formation was higher than that of positive control (TAP) and ranged
between 61.8% of inhibition at MIC/8 (0.125 mg ml-1) and 47.2% at MIC/4 (0.25 mg ml-1). On the other hand,
disruption of preformed biofilm with the EO was somewhat lower than that obtained with TAP; the inhibitions
ranged 22–36% and 25.5–42.6%, respectively. In addition, the only concentration that was used in both procedures
(MIC/2, 0.5 mg ml-1) induced the opposite effect, that is, inhibited the biofilm formation (53.8%), but also induced
proliferation of already formed biofilm (stimulation 14%, Figure 2).
Formulation & characterization of C. citratus EO nanoemulsion
Immediately after emulsion synthesis, calculated number weighted mean particle diameter and the polydispersity
index of the nanoemulsion were 95 ± 23 nm and 0.17 ± 3, respectively. Furthermore, the time dynamics of intensity
weighted size distributions (Figure 3) and polydispersity indices (Table 4) indicated that the nanoemulsion remained
stable during the whole storage period (4 weeks).
Antioxidant activity of C. citratus EO nanoemulsion
Both antioxidant assays revealed the low antioxidant activity of formulated nanoemulsion (Figure 4), which was
expected, since the activity was presented in respect to concentrations of EO (active principle) within the nanoemul-
sion, being relatively low. The DPPH test showed scavenging potential with maximal inhibition determined at
12.9%, while inhibition of LP in the TBA assay was up to 24.0%. The fact that the inhibitory values for approxi-
mately similar concentrations of sole EO and the EO in the nanoemulsion (0.125 and 0.113 mg ml-1, respectively)
were similar, it confirmed that preparation of nanoemulsion did not affect the antioxidant activity of sole C. citratus
EO.
The impact of irrigation procedure including C. citratus EO nanoemulsion on the E. faecalis biofilm
cell viability
The outcomes of intracanal biofilm disruption assay, conducted in ex vivo teeth, confirmed the high inhibitory
potential of irrigation procedure including C. citratus EO nanoemulsion toward E. faecalis intracanal biofilm (log
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Figure 4. Antioxidative potential of the
Cymbopogon citratus essential oil
nanoemulsion. Presented values are averages
with standard deviations, obtained for two
individual experiments performed in
triplicates.
TAP: Triple antibiotic paste.
Table 5. The impact of irrigation procedures (including or not Cymbopogon citratus EO nanoemulsion) on the
Enterococcus faecalis biofilm cell viability within the root canals of extracted teeth.
Log CFU Irrigation procedure A
(NaOCl + sterile saline + Cymbopogon
citratus EO nanoemulsion†)
Irrigation procedure B
(NaOCl + sterile saline + negative control‡)
Irrigation procedure C
(sole NaOCl§)
Before After Before After Before After
Log CFU 5.92 ± 0.13 2.52 ± 0.66 5.98 ± 0.03 4.67 ± 0.03 6.60 ± 0.60 4.82 ± 0.13
 (log CFU)¶ 3.4 1.31 1.78
†Nanoemulsion content: C. citratus EO (2.5%, v/v), Tween 80 (0.25%, v/v), ethanol (2.5%, v/v), distilled water (added to 100% content).
‡Nanoemulsion negative control content: Tween 80 (0.25%, v/v), ethanol (2.5%, v/v), distilled water (added to 100% content).
§NaOCl solution contained 0.5% of active Cl2.
¶The value of biofilm reduction after irrigation treatment, determined by subtraction of log CFU values before and after each irrigation. The results are expressed as the average ± standard
deviation of two individual experiments performed in triplicates.
EO: Essential oil.
CFU 3.4, Table 5); the reduction was remarkably higher than those achieved with the final irrigation solution
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without EO (negative control) and with the sole NaOCl (log CFU were 1.31 and 1.78, respectively).
Discussion
In this study antioxidative, antibacterial and antibiofilm properties of the C. citratus EO have been investigated.
The preparation and assessment of C. citratus EO nanoemulsion was particularly stressed, and involved in vitro
determination of its antioxidative potential and inhibitory potential against E. faecalis biofilm within extracted teeth
root canals. This was of our special interest as a kind of investigation that is a step toward the practical application
of C. citratus EO in infected root canal therapy.
Biofilm of E. faecalis has been selected in accordance with scientific evidences confirming this pathogen as the
most commonly isolated bacterial species in endodontic cases, which need retreatment [31,32]. This is related to
its capabilities to invade and bind to collagen in dentinal tubules, to survive in prolonged periods of starvation
until nutritional supply becomes available again [33] and to overcome activities of the commonly used intracanal
antimicrobials [4,5,33]. Being aware of all the above-mentioned, in addition to findings that E. faecalis could be
resistant to various antibiotics, including the TAP constituents [34–36], some authors have already pursued the possible
alternatives among EOs [37,38]. These authors have demonstrated the efficiency of Aloe vera, Zataria multiflora and
Matricaria chamomilla oils against E. faecalis within the root canals. Our previous study also suggested C. martinii
and Thymus zygis EOs, as possible supportive antimicrobials against multispecies biofilm including E. faecalis [18].
Prescreening of the antibacterial properties of C. citratus EO in the microdilution assay, indicating a notable
antibacterial potential, is in agreement with the findings of Bassole [39]. In vitro testing of the antibiofilm activity
showed the high efficiency in inhibition of biofilm formation and in disruption of the preformed biofilm. In a
recent study, Ortega-Ramirez et al. [40] also presented the high inhibitory impact of the same EO, but against
biofilm formed by Escherichia coli strains. In this study comparison of effectivity against preformed and emerging
E. faecalis biofilms pointed out the more pronounced activity during biofilm formation. A similar was also observed
by Costa et al. [41] and Correa et al. [42], and could be explained by the fact that planktonic cells, being exposed
during biofilm formation, are more vulnerable than the cells being protected by biofilm matrix [43,44]. Considering
possible mechanism underlying the observed antibiofilm properties, the suggestions of Ortega-Ramirez et al. [40]
and Gao et al. [45] seem to be even more interesting as they showed that C. citratus EO reduced the viability of the
cells and disrupt the biofilm matrix, at least formed by E. coli and cross-kingdom pathogens Staphylococcus aureus
and Candida spp., respectively.
Application of pure EO during a root canal treatment is limited due to its viscosity and hydrophobicity, which
makes it hard to remove from the root canal prior to the final step of the infected root canal treatment – its
obturation. Therefore, the formulation of the most appropriate EO delivery system intended for use in the root
canal disinfection and with no impediment to the following step in the endodontic procedure is considered highly
desirable. In this study, we designed the nanoemulsion–liquid dispersion of the C. citratus EO in an aqueous
phase stabilized by the surfactant Tween 80. Concerning a fact that the emulsions are unstable systems, EOs-based
nanoemulsion has required the evaluation of the stability throughout the storage time [46]. We monitored the basic
parameters through several weeks and pointed out that the nanoemulsion was stable for up to 4 weeks.
Bearing in mind that the nanoemulsification of EOs increases the overall antimicrobial activity [47], this approach
is valuable not only because of optimizing delivery in root canals but also due to antibacterial demands. Moreover,
Bonferoni et al. [48] has already formulated specific C. citratus EO nanoemulsion characterized by the improved
antimicrobial effect compared with that of the sole EO. The results provided by the screening of antibiofilm effect on
extracted teeth showed remarkable potential of the nanoemulsion-involved irrigation against enterococcal biofilm
established in root canals. It is worth to note that the reduction of log CFU provided by a procedure including
EO nanoemulsion was >3 log, being defined by the National Committee for Clinical Laboratory Standards [49]
as a border for considering the bactericidal activity. The fact that both of other irrigation procedures without the
nanoemulsion (negative control and sole NaOCl) induced weak antibiofilm effect confirmed that EO nanoemulsion
contributed remarkably to overall activity.
Bearing in mind that conventional endodontic treatments, including chlorhexidine, calcium hydroxide and also
the NaOCl used in this study, contribute to ROS production consequently inducing oxidative stress [7–9], we had
to focus also on the antioxidative potential. It was screened for both, the EO and EO-based nanoemulsion, in
the DPPH and TBA assays. Results of DPPH assay pointed out the notable scavenging activity of the C. citratus
EO, which was in agreement with previous studies [19,20]. Searching for the antioxidative potential in the TBA
assay indicated that EO could additionally be protective on the cell membranes, due to its potential to reduce LP.
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This is of special importance as this is the first report indicating potential of the C. citratus EO to prevent LP
on the cell membranes. According to the facts that the EO concentration in the nanoemulsion is low, as well as
that only EO could contribute to its antioxidative effect, both scavenging capacity and potential to inhibit LP of
the EO-based nanoemulsion were expectedly lower. However, the antioxidative properties do exist and could be
beneficial particularly following the NaOCl-induced ROS production [7] during the standard irrigation procedure.
In order to explain the background of the presented antibacterial, antibiofilm and antioxidant activities of the C.
citratus EO and its nanoemulsion potential active compounds among C. citratus EO constituents were also explored.
The fact that the EO is dominantly abundant with citrals A and B (i.e., geranial and neral), being characterized
as active aldehydes, which could interfere with electron transfer and vital nitrogen-containing components, for
example, proteins and nucleic acids of the bacteria [50], it seem that they could be of interest for the observed
antimicrobial activity. Accordingly, the citrals could be responsible for the bacterial growth inhibition (i.e. for the
observed antibacterial activity). Antibiofilm effect could also be attributed to citrals as a few recent studies confirmed
their high antibacterial and antibiofilm activity against numerous bacterial species, including E. faecalis [51–54]. The
recent study of Gao et al. [45] demonstrating that they possess remarkable potential to diminish all components
of biofilm matrix (nucleic acid, proteins and carbohydrates) of combined pathogens S. aureus and Candida spp.,
additionally strengthen this claim.
On the other hand, several studies confirmed antioxidant potential of geraniol [55–58] other major C. citratus EO
constituent. Interestingly, Widelska [59] suggested that other EO constituents, geranial and neral, have not been
responsible for antioxidant activity of C. citratus EO; the author tested antioxidant activity of this EO along with
sole neral/geranial, and explained that antioxidant potential of complete EO should be attributed to synergism of
the neral/geranial with other EO constituents.
Conclusion
In this study we presented promising properties of the C. citratus EO nanoemulsion: reductive potential against
E. faecalis biofilm formed in infected teeth root canals, and local tissue protective effect against oxidative stress
induced by conventional irrigants. Presented results encourage further investigation in order to upgrade the C.
citratus EO-based nanoemulsion, in order to formulate suitable adjuvant being useful in the future endodontic
practice.
Future perspective
Bearing in mind that eradication of E. faecalis within infected root canal is recognized as highly problematic in
dental practice, our results strongly encourage future studies, including the clinical ones, of new antimicrobials in
the forms of the nanoemulsions based on EOs, being proved for remarkable antibacterial activity and no resistance
issues. Encouraging results of in vitro and ex vivo assays presented in this study, provide a basis for the expectation
that the EOs based nanoemulsions would successfully combat with E. faecalis and other pathogens of clinical
relevance, within root canals in vivo. Moreover, beneficial antioxidant properties of the EOs additionally support
their use as an active principle for preparation of the nanoemulsion, which should be protective against oxidative
stress. Clinical confirmation of the ROS neutralization and bacterial elimination would be a serious breakthrough
in the endodontics.
Authors expect that the future clinical studies would confirm these in vitro obtained results, enabling the usage
of the EO-based nanoemulsion, as a part of common routine in dental practice.
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Summary points
• Cymbopogon citratus essential oil (EO) has been chemically characterized and proved to possess notable
antibacterial activity.
• EO proved highly efficient in the inhibition of biofilm formation as well as in disruption of the preformed biofilm.
• The most appropriate EO delivery system for the root canal disinfection was provided through formulation of
EO-based nanoemulsion.
• Nanoemulsion characterization, involving determination of calculated numbers weighted mean particle
diameters and polydispersity indices, pointed out that it remained stable up to 4 weeks.
• Bactericidal activity toward Enterococcus faecalis was confirmed with irrigation procedure including the EO
nanoemulsion in ex vivo root canals.
• Antioxidative properties of EO and its nanoemulsion could be considered as beneficial, especially after irrigation
procedures containing reactive oxygen species producer NaOCl.
• Citrals A and B (i.e., geranial and neral) may be responsible for observed antibacterial and antibiofilm properties
of the EO and its nanoemulsion.
• Geraniol as well as citrals interactions with the other constituents of the EO may be responsible for the observed
antioxidative potential.
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4. Siqueira JF, Rôças IN. Clinical implications and microbiology of bacterial persistence after treatment procedures. J. Endod. 34(11),
1291–1301.e3 (2008).
5. Shokraneh A, Farhad AR, Farhadi N, Saatchi M, Hasheminia SM. Antibacterial effect of triantibiotic mixture versus calcium hydroxide
in combination with active agents against Enterococcus faecalis biofilm. Dent. Mater. J. 33(6), 733–738 (2014).
6. Cieplik F, Jakubovics NS, Buchalla W, Maisch T, Hellwig E, Al-Ahmad A. Resistance toward chlorhexidine in oral bacteria – is there
cause for concern? Front. Microbiol. 10(587), 1–11 (2019).
7. Shiozawa A. Characterization of reactive oxygen species generated from the mixture of NaClO and H2O2 used as root canal irrigants. J.
Endod. 26(1), 11–15 (2000).
• Manuscript suggests reactive oxygen species in endodontic practice.
8. Barbin LE, Saquy PC, Guedes DFC, Sousa-Neto MD, Estrela C, Pécora JD. Determination of para-chloroaniline and reactive oxygen
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